Ionis Pharmaceuticals (IONS) PT Lowered to $60 at Raymond James

February 20, 2025 5:50 AM

Raymond James analyst Gary Nachman lowered the price target on Ionis Pharmaceuticals (NASDAQ: IONS) to $60.00 (from $61.00) while maintaining ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found